obp Surgical→CooperSurgical (CooperCompanies)
Acquisition · Cash · COO · announced Aug 1, 2024
Announced
Aug 1, 2024
Closed
Aug 1, 2024
Economics
Cash()
Pre-deal · pre-deal mark: 2024, year precision · Cooper Companies press release — obp Surgical acquisition, 2024
~$100M (CooperCompanies press release; SEC 10-K FY2024 confirms $100.0M)
Target
obp Surgical
Gynecological Surgery · Clinical / therapeutic
HQ San Ramon, CA · Founded 2018
Single-use cordless surgical retractors (ONETRAC) with integrated LED light and smoke evacuation — used in gynecological and general surgery
- CooperCompanies investor relations — Globe Newswire (Aug 1, 2024)
- SEC EDGAR — CooperCompanies 10-K FY2024
Acquirer
CooperSurgical (CooperCompanies) (COO)
Fertility
HQ Trumbull, CT
Why this buyer
Curated copy from the verified dataset — not an 8-K LLM summary
ONETRAC cordless illuminated retractors complement CooperSurgical's INSORB, Lone Star, and Doppler surgical device portfolio
Evidence ladder
Secondary (press / IR)
CooperCompanies investor relations — Globe Newswire (Aug 1, 2024)
Primary (regulatory / filing)
SEC 10-K FY2024
SEC EDGAR filings (ticker locator)Primary (regulatory / filing)
SEC EDGAR 8-K https://www.sec.gov/Archives/edgar/data/711404/000071140425000010/cooperq12025pressrelease.htm
Open source
Limitations
- ~$100M (CooperCompanies press release; SEC 10-K FY2024 confirms $100.0M)
- Pre-deal valuation sourced from: Cooper Companies press release — obp Surgical acquisition, 2024. Pre-deal market-cap and funding citations do not corroborate the acquisition.
Valuation peers · Gynecological Surgery
Same sector, same deal type, announced within ±3 years, disclosed value within 0.25×–4× of this transaction. Ranked by evidence class, then same acquirer.
| Target | Acquirer | Announced | Value | Why included |
|---|---|---|---|---|
| Gynesonics | Hologic | Sep 15, 2024 | same evidence class | |
| Bolder Surgical | Hologic | Oct 14, 2021 | same evidence class |
Other verified deals by CooperSurgical (CooperCompanies)
Acquirer program history not already listed as a valuation peer or adjacency row.
| Target | Acquirer | Announced | Value | Sector |
|---|---|---|---|---|
| ZyMōt Fertility | CooperSurgical | Jun 10, 2024 | Undisclosed | Fertility |
| Cook Medical Reproductive Health | CooperSurgical (CooperCompanies) | Feb 7, 2022 | Undisclosed | Fertility |
| Generate Life Sciences | CooperSurgical (CooperCompanies) | Nov 10, 2021 | Reproductive Health | |
| ORIGIO a/s | CooperSurgical (CooperCompanies) | Jun 4, 2012 | Fertility |
Patient empowerment context
Patient empowerment baseline (HLTH 2022)
No curated mapping — obp Surgical (Gynecological Surgery). HLTH/Outcomes4Me 2022 baseline is Breast cancer care continuum (HLTH 2022). No curated mapping for this target in the verified crosswalk.
Research workspace (includes heuristic crosswalk) →Related verified workspaces
Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.
Curated verified dataset v9 · updated 2026-09-20 · 3 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.